Related Experiment Video
Updated: Jul 30, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
[Atypical initial manifestation of primary hyperaldosteronism]
D Arnés-García1, M L Tornero-Divieso1, A Rosales-Castillo1
1Servicio de Medicina Interna, Hospital Universitario Virgen de las Nieves, Granada, España.
Primary hyperaldosteronism, a common cause of secondary arterial hypertension, typically presents with high blood pressure and low potassium. Rarely, it can manifest as severe muscle pain and breakdown due to extreme hypokalemia.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Arterial hypertension affects a significant portion of the population, with approximately 10% stemming from secondary causes.
- Primary hyperaldosteronism is a frequent secondary cause, classically presenting with hypertension, metabolic alkalosis, and hypokalemia.
Observation:
- This case highlights an atypical presentation of primary hyperaldosteronism.
- The patient experienced significant muscle weakness and myalgia.
Findings:
- These symptoms were attributed to rhabdomyolysis, a severe consequence of profound hypokalemia.
- This underscores the potential for unusual clinical manifestations in primary hyperaldosteronism.
Implications:
- Recognizing atypical presentations is crucial for timely diagnosis and management of primary hyperaldosteronism.
- Early intervention can prevent severe complications like rhabdomyolysis and associated muscle damage.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Hormonal Regulation

